Author:
Guo Bingbing,Pei Jingjing,Xu Yin,Wang Yajie,Jiang Xinye
Abstract
AbstractTo explore the application value of early standardized management in the delivery of neonates of pregnant women with gestational diabetes mellitus (GDM). Parturient diagnosed with GDM and their offspring were selected in our hospital from January 1, 2015 to December 31, 2017 to underwent early standardized management. Non-GDM pregnant women and their offspring were selected as the control group. The growth and development of children aged 0–5 years in the two groups were longitudinally followed up, and the mixed linear model was used to evaluate and compare the growth trajectories. There was no significant difference in height and weight between the two groups at 1 year old (P > 0.05), but the BMI of the GDM group was significantly higher than that in the control group. After 1 year of age, both groups of offspring were similar in height, weight, and BMI, and these similarities persisted at 2, 3, 4, and 5 years of age. After controlling for covariates, the weight, length/height of the two groups of children were slightly different in the growth trajectories between 0–1 years old, 1–2 years old, 2–3 years old, 3–4 years old, and 4–5 years old with no statistical significance (P > 0.05). Although growth differences between the two groups of children were detected within 1 year of age, there were no significant differences in growth trajectories from 1 to 5 years between two groups, which proved that early standardized management has positive significance.
Funder
high-level talent training project of Wuxi Taihu Talent Plan
the 21st batch of Wuxi science and technology innovation and entrepreneurship projects
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Szmuilowicz, E. D., Josefson, J. L. & Metzger, B. E. Gestational diabetes mellitus. Endocrinol. Metab. Clin. North Am. 48(3), 479–493 (2019).
2. Kim, K. S., Hong, S., Han, K. & Park, C. Y. The clinical characteristics of gestational diabetes mellitus in Korea: A National Health Information Database Study. Endocrinol. Metab. (Seoul) 36(3), 628–636 (2021).
3. Guariguata, L., Linnenkamp, U., Beagley, J., Whiting, D. R. & Cho, N. H. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res. Clin. Pract. 103(2), 176–185 (2014).
4. Krejci, H. et al. The incidence of gestational diabetes mellitus before and after the introduction of HAPO diagnostic criteria. Ceska Gynekol. 84(6), 404–411 (2019).
5. Jawad, F. & Ejaz, K. Gestational diabetes mellitus in South Asia: Epidemiology. J .Pak. Med. Assoc. 66(9 Suppl 1), S5–S7 (2016).